(Q44138863)
Statements
Phase I/IIa safety, immunogenicity, and efficacy trial of NYVAC-Pf7, a pox-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria (English)
W R Ballou
P F Sun
D E Lanar
B T Wellde
B T Hall
K Kester
J A Stoute
A Magill
U Krzych
L Farley
R A Wirtz
J C Sadoff
D C Kaslow
S Kumar
L W Church
J M Crutcher
B Wizel
S Hoffman
A V Hill
J A Tine
K P Guito
C de Taisne
1 June 1998